Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Pardhe MD"'
Autor:
Diamos AG; Center for Immunotherapy, Vaccines, and Virotherapy, Biodesign Institute at Arizona State University (ASU), School of Life Sciences, Arizona State University, Tempe, AZ, United States., Pardhe MD; Center for Immunotherapy, Vaccines, and Virotherapy, Biodesign Institute at Arizona State University (ASU), School of Life Sciences, Arizona State University, Tempe, AZ, United States., Bergeman MH; Center for Immunotherapy, Vaccines, and Virotherapy, Biodesign Institute at Arizona State University (ASU), School of Life Sciences, Arizona State University, Tempe, AZ, United States., Kamzina AS; Center for Immunotherapy, Vaccines, and Virotherapy, Biodesign Institute at Arizona State University (ASU), School of Life Sciences, Arizona State University, Tempe, AZ, United States., DiPalma MP; Center for Immunotherapy, Vaccines, and Virotherapy, Biodesign Institute at Arizona State University (ASU), School of Life Sciences, Arizona State University, Tempe, AZ, United States., Aman S; Center for Immunotherapy, Vaccines, and Virotherapy, Biodesign Institute at Arizona State University (ASU), School of Life Sciences, Arizona State University, Tempe, AZ, United States., Chaves A; Center for Immunotherapy, Vaccines, and Virotherapy, Biodesign Institute at Arizona State University (ASU), School of Life Sciences, Arizona State University, Tempe, AZ, United States., Lowe K; Center for Immunotherapy, Vaccines, and Virotherapy, Biodesign Institute at Arizona State University (ASU), School of Life Sciences, Arizona State University, Tempe, AZ, United States., Kilbourne J; Center for Immunotherapy, Vaccines, and Virotherapy, Biodesign Institute at Arizona State University (ASU), School of Life Sciences, Arizona State University, Tempe, AZ, United States., Hogue IB; Center for Immunotherapy, Vaccines, and Virotherapy, Biodesign Institute at Arizona State University (ASU), School of Life Sciences, Arizona State University, Tempe, AZ, United States., Mason HS; Center for Immunotherapy, Vaccines, and Virotherapy, Biodesign Institute at Arizona State University (ASU), School of Life Sciences, Arizona State University, Tempe, AZ, United States.
Publikováno v:
Frontiers in immunology [Front Immunol] 2023 May 02; Vol. 14, pp. 1085911. Date of Electronic Publication: 2023 May 02 (Print Publication: 2023).
Autor:
Diamos AG; Center for Immunotherapy, Vaccines, and Virotherapy, Biodesign Institute, Arizona State University, Tempe, AZ, United States.; School of Life Sciences, Arizona State University, Tempe, AZ, United States., Pardhe MD; Center for Immunotherapy, Vaccines, and Virotherapy, Biodesign Institute, Arizona State University, Tempe, AZ, United States.; School of Life Sciences, Arizona State University, Tempe, AZ, United States., Sun H; Center for Immunotherapy, Vaccines, and Virotherapy, Biodesign Institute, Arizona State University, Tempe, AZ, United States.; School of Life Sciences, Arizona State University, Tempe, AZ, United States., Hunter JGL; Center for Immunotherapy, Vaccines, and Virotherapy, Biodesign Institute, Arizona State University, Tempe, AZ, United States.; School of Life Sciences, Arizona State University, Tempe, AZ, United States., Kilbourne J; Center for Immunotherapy, Vaccines, and Virotherapy, Biodesign Institute, Arizona State University, Tempe, AZ, United States.; School of Life Sciences, Arizona State University, Tempe, AZ, United States., Chen Q; Center for Immunotherapy, Vaccines, and Virotherapy, Biodesign Institute, Arizona State University, Tempe, AZ, United States.; School of Life Sciences, Arizona State University, Tempe, AZ, United States., Mason HS; Center for Immunotherapy, Vaccines, and Virotherapy, Biodesign Institute, Arizona State University, Tempe, AZ, United States.; School of Life Sciences, Arizona State University, Tempe, AZ, United States.
Publikováno v:
Frontiers in immunology [Front Immunol] 2020 Dec 04; Vol. 11, pp. 576012. Date of Electronic Publication: 2020 Dec 04 (Print Publication: 2020).
Autor:
Diamos AG; Center for Immunotherapy, Vaccines and Virotherapy, The Biodesign Institute, and The School of Life Sciences, Arizona State University, Tempe, AZ 85287-4501, United States., Pardhe MD; Center for Immunotherapy, Vaccines and Virotherapy, The Biodesign Institute, and The School of Life Sciences, Arizona State University, Tempe, AZ 85287-4501, United States., Sun H; Center for Immunotherapy, Vaccines and Virotherapy, The Biodesign Institute, and The School of Life Sciences, Arizona State University, Tempe, AZ 85287-4501, United States., Hunter JGL; Center for Immunotherapy, Vaccines and Virotherapy, The Biodesign Institute, and The School of Life Sciences, Arizona State University, Tempe, AZ 85287-4501, United States., Mor T; Center for Immunotherapy, Vaccines and Virotherapy, The Biodesign Institute, and The School of Life Sciences, Arizona State University, Tempe, AZ 85287-4501, United States., Meador L; Center for Immunotherapy, Vaccines and Virotherapy, The Biodesign Institute, and The School of Life Sciences, Arizona State University, Tempe, AZ 85287-4501, United States., Kilbourne J; Center for Immunotherapy, Vaccines and Virotherapy, The Biodesign Institute, and The School of Life Sciences, Arizona State University, Tempe, AZ 85287-4501, United States., Chen Q; Center for Immunotherapy, Vaccines and Virotherapy, The Biodesign Institute, and The School of Life Sciences, Arizona State University, Tempe, AZ 85287-4501, United States., Mason HS; Center for Immunotherapy, Vaccines and Virotherapy, The Biodesign Institute, and The School of Life Sciences, Arizona State University, Tempe, AZ 85287-4501, United States. Electronic address: hugh.mason@asu.edu.
Publikováno v:
Vaccine [Vaccine] 2020 Apr 16; Vol. 38 (18), pp. 3455-3463. Date of Electronic Publication: 2020 Mar 12.
Autor:
Diamos AG; Center for Immunotherapy, Vaccines and Virotherapy, The Biodesign Institute, Arizona State University, Tempe, AZ, United States.; School of Life Sciences, Arizona State University, Tempe, AZ, United States., Hunter JGL; Center for Immunotherapy, Vaccines and Virotherapy, The Biodesign Institute, Arizona State University, Tempe, AZ, United States.; School of Life Sciences, Arizona State University, Tempe, AZ, United States., Pardhe MD; Center for Immunotherapy, Vaccines and Virotherapy, The Biodesign Institute, Arizona State University, Tempe, AZ, United States.; School of Life Sciences, Arizona State University, Tempe, AZ, United States., Rosenthal SH; Center for Immunotherapy, Vaccines and Virotherapy, The Biodesign Institute, Arizona State University, Tempe, AZ, United States.; School of Life Sciences, Arizona State University, Tempe, AZ, United States., Sun H; Center for Immunotherapy, Vaccines and Virotherapy, The Biodesign Institute, Arizona State University, Tempe, AZ, United States.; School of Life Sciences, Arizona State University, Tempe, AZ, United States., Foster BC; School of Life Sciences, Arizona State University, Tempe, AZ, United States., DiPalma MP; Center for Immunotherapy, Vaccines and Virotherapy, The Biodesign Institute, Arizona State University, Tempe, AZ, United States.; School of Life Sciences, Arizona State University, Tempe, AZ, United States., Chen Q; Center for Immunotherapy, Vaccines and Virotherapy, The Biodesign Institute, Arizona State University, Tempe, AZ, United States.; School of Life Sciences, Arizona State University, Tempe, AZ, United States., Mason HS; Center for Immunotherapy, Vaccines and Virotherapy, The Biodesign Institute, Arizona State University, Tempe, AZ, United States.; School of Life Sciences, Arizona State University, Tempe, AZ, United States.
Publikováno v:
Frontiers in bioengineering and biotechnology [Front Bioeng Biotechnol] 2020 Jan 17; Vol. 7, pp. 472. Date of Electronic Publication: 2020 Jan 17 (Print Publication: 2019).